TGV Sraac Ltd

TGV Sraac Ltd

₹ 97.4 0.44%
01 Mar - close price
About

Incorporated in 1981, TGV SRAAC Ltd is a flagship company of the TGV Group. It manufactures Chlor-Alkali products, Castor Derivatives and Fatty Acids[1]

Key Points

Product Profile:[1]
Company's operations are divided into 3 segments viz. Chemicals Division, Oils and Fats Division and Power Division.
a) Castor Derivatives:[2] Hydrogenated Castor Oil, 12-Hydroxy Stearic Acid, Ricinoleic Acid, Refined Castor Oil, Methyl, etc.
b) Chlor-Alkali Products:[3] Caustic Soda, Liquid Chlorine, Hydrochloric Acid, Caustic Potash, Sodium Hypochlorite (Liquid), Barium Sulphate (Precipitated powder), Hydrogen Gas, Potassium Carbonate
c) Fatty Acids:[4] Stearic Acid, Soap Noodles, Glycerine (Refined
/ Chemically Pure), Hydrogenated Palm Stearin
d) Chloromethanes:[5] Methyl Chloride, Methylene Chloride, Chloroform, Carbon Tetra Chloride
e) Toilet Soap:[6] Royal Saffron Sandal, Cool Lime, Royal HE-MAN, Baby Doctor, Royal Rose
f) Power Projects:[7][8]
Company has established power generation for captive use and for commercial purposes. There are no commercial operations at Bellary Power Plant due to expiry of Power Purchase Agreement (PPA) by KPTCL. Company is looking out for other viable options including its sale or relocation of the Plant

  • Market Cap 1,043 Cr.
  • Current Price 97.4
  • High / Low 133 / 86.2
  • Stock P/E 14.9
  • Book Value 101
  • Dividend Yield 1.03 %
  • ROCE 38.0 %
  • ROE 40.4 %
  • Face Value 10.0

Pros

  • Company has reduced debt.
  • Stock is trading at 0.96 times its book value
  • Company has delivered good profit growth of 64.9% CAGR over last 5 years

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
266 254 251 305 436 534 596 609 592 529 415 360 402
228 224 211 256 341 405 419 453 449 462 368 333 358
Operating Profit 37 30 39 49 94 129 177 157 143 67 48 27 44
OPM % 14% 12% 16% 16% 22% 24% 30% 26% 24% 13% 11% 8% 11%
2 5 1 1 1 3 1 1 1 3 5 24 4
Interest 9 10 9 11 13 8 7 13 5 9 5 5 6
Depreciation 16 16 16 17 18 18 18 18 19 19 20 21 21
Profit before tax 14 9 16 23 64 106 153 127 120 41 27 25 21
Tax % 31% 74% 37% 36% 36% 36% 3% 26% 27% 24% 27% 27% 27%
10 2 10 15 41 68 148 95 88 32 20 19 15
EPS in Rs 0.92 0.22 0.91 1.37 3.86 6.39 13.80 8.83 8.18 2.95 1.84 1.74 1.42
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
782 817 769 777 816 908 1,046 1,205 1,040 1,009 1,525 2,326 1,707
681 695 670 669 710 776 866 974 884 860 1,219 1,786 1,521
Operating Profit 101 121 99 108 107 132 180 231 157 149 306 539 185
OPM % 13% 15% 13% 14% 13% 15% 17% 19% 15% 15% 20% 23% 11%
5 4 -19 0 5 9 7 -6 8 10 7 6 36
Interest 42 45 40 40 44 60 58 71 44 48 35 30 25
Depreciation 37 41 36 36 35 47 77 58 56 63 69 74 81
Profit before tax 28 40 4 32 33 34 53 95 64 48 209 442 115
Tax % 50% 6% -11% 30% 26% 52% 44% 28% 26% 40% 36% 18%
14 38 5 22 24 17 30 68 47 29 134 362 85
EPS in Rs 5.31 0.64 2.81 2.95 1.90 3.22 7.08 4.65 2.70 12.53 33.77 7.95
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 3%
Compounded Sales Growth
10 Years: 11%
5 Years: 17%
3 Years: 31%
TTM: -27%
Compounded Profit Growth
10 Years: 25%
5 Years: 65%
3 Years: 97%
TTM: -82%
Stock Price CAGR
10 Years: 31%
5 Years: 23%
3 Years: 50%
1 Year: -9%
Return on Equity
10 Years: 17%
5 Years: 21%
3 Years: 24%
Last Year: 40%

Balance Sheet

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Sep 2023
Equity Capital 68 71 75 79 83 87 92 97 102 107 107 107 107
Reserves 135 172 177 199 227 258 290 373 430 503 636 939 979
Preference Capital 19 19 19 19 19 19 0 0 0 0 0 0
385 322 313 327 432 457 439 328 420 499 461 234 238
207 212 231 213 230 276 269 298 323 344 393 403 360
Total Liabilities 794 777 796 818 972 1,078 1,091 1,095 1,275 1,453 1,598 1,683 1,684
460 456 431 444 660 698 669 636 808 774 902 1,042 1,023
CWIP 53 70 126 124 0 0 13 77 29 125 55 11 53
Investments 2 2 2 2 2 9 14 10 8 89 89 31 36
279 250 237 248 309 371 394 373 430 465 551 600 572
Total Assets 794 777 796 818 972 1,078 1,091 1,095 1,275 1,453 1,598 1,683 1,684

Cash Flows

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
105 27 78 65 50 142 153 202 122 132 168 429
-67 -53 -75 -52 -132 -109 -75 -55 -188 -163 -147 -169
-2 -3 -12 -2 91 -33 -76 -145 65 58 -38 -255
Net Cash Flow 36 -29 -9 11 9 -0 2 2 -0 26 -18 5

Ratios

Figures in Rs. Crores

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 31 27 25 25 29 30 37 30 29 36 56 36
Inventory Days 71 60 77 50 82 79 89 125 167 126 101 90
Days Payable 66 74 93 65 77 98 80 67 73 81 66 42
Cash Conversion Cycle 36 13 8 10 34 11 45 89 123 81 90 84
Working Capital Days 16 3 -9 -1 21 7 11 35 46 37 61 40
ROCE % 12% 14% 12% 13% 11% 12% 13% 22% 12% 9% 21% 38%

Shareholding Pattern

Numbers in percentages

Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
63.18% 63.18% 63.18% 63.18% 63.18% 63.18% 63.18% 63.18% 63.18% 63.18% 63.18% 63.18%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.28% 1.10% 1.05% 0.72% 0.13% 0.00%
0.51% 0.29% 0.27% 0.24% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02% 0.02%
36.31% 36.54% 36.56% 36.58% 36.80% 36.80% 35.51% 35.70% 35.75% 36.08% 36.67% 36.80%
No. of Shareholders 33,14233,62333,17733,46034,03536,61542,11343,83546,34850,27159,44160,986

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents